Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1084PDF: 396HTML: 246 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3730PDF: 2605HTML: 1637 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3357PDF: 974HTML: 3312 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2607PDF: 1753HTML: 593 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1597PDF: 932HTML: 1019figures: 214table 1: 211table2: 212table3: 218 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7888PDF: 2494HTML: 2120Table 1.: 251Table 2.: 261Table 3.: 242Table 4.: 238 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2703PDF: 1678HTML: 2453Table1: 214 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2088PDF: 451HTML: 233 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1194PDF: 544HTML: 390 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1916PDF: 840HTML: 232 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1745PDF: 641HTML: 292 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1502PDF: 969HTML: 255 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2241PDF: 1042HTML: 4097Cover Letter: 244Figure 1: 259Figure 2: 251Table 1: 233 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4629PDF: 1791HTML: 1244 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1479PDF: 860HTML: 3138 -
Skin Involvement in Primary Systemic Amyloidosis
1725PDF: 930HTML: 4424Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 201Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 179Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 207 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2314PDF: 761HTML: 2147Untitled: 252Untitled: 174Untitled: 207Untitled: 179Untitled: 197Untitled: 205Untitled: 212 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4162PDF: 1381HTML: 2539 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1691PDF: 601HTML: 898 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1423PDF: 488HTML: 18626Figure 1: 189Figure 2: 168Figure 3: 186Figure 4: 221Figure 5: 199 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2338PDF: 2122HTML: 222 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
1202PDF: 881HTML: 613 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1249PDF: 792HTML: 1532Figure 1: 223Figure 2: 218







